All Stories

  1. Fractionated photothermal therapy in a murine tumor model: comparison with single dose
  2. Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts
  3. Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction
  4. PET imaging with copper-64 as a tool for real-time in vivo investigations of the necessity for cross-linking of polymeric micelles in nanomedicine
  5. Tracer for HER2 cancer imaging with PET
  6. NEC - neuroendocrine carcinomas review
  7. The impact of weakly bound 89Zr on preclinical studies: Non-specific accumulation in solid tumors and aspergillus infection
  8. Automated synthesis and PET evaluation of both enantiomers of [18F]FMISO
  9. Pharmacokinetic Analysis of 64Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice
  10. Synthesis and characterization of18F-labeled active site inhibited factor VII (ASIS)
  11. Dental artifacts in the head and neck region: implications for Dixon-based attenuation correction in PET/MR
  12. 18F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma
  13. Goblet Cell Carcinoids: Characteristics of a Danish Cohort of 83 Patients
  14. Injectable Colloidal Gold for Use in Intrafractional 2D Image-Guided Radiation Therapy
  15. Comparison of the Photothermal Efficiency of Different Types of Plasmonic Nanoparticles in vitro and in vivo
  16. Imaging Atherosclerosis with Hybrid Positron Emission Tomography/Magnetic Resonance Imaging
  17. Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1
  18. HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study
  19. Impact of incorrect tissue classification in Dixon-based MR-AC: fat-water tissue inversion
  20. Efficient Regioselective Ring Opening of Activated Aziridine-2-Carboxylates with [18 F]Fluoride
  21. PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature
  22. Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study
  23. Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study
  24. uPAR Targeted Radionuclide Therapy with 177 Lu-DOTA-AE105 Inhibits Dissemination of Metastatic Prostate Cancer
  25. Sparsely sampled MR navigators as a practical tool for quality control and correction of head motion in simultaneous PET/MR
  26. Identification and characterization of human brown adipose tissue (BAT) content and metabolism in adults using [18F]-FDG PET/MR – a pilot study
  27. PET/MR imaging of sarcomas: effect of PET quantification by classification of tissue
  28. Geometric distortions of diffusion weighted imaging of the head/neck in combined PET/MR: optimization of image acquisition and post-processing correction for oncology applications
  29. Quantification of myocardial perfusion using cardiac magnetic resonance imaging correlates significantly to rubidium-82 positron emission tomography in patients with severe coronary artery disease: A preliminary study
  30. The Use of Longitudinal 18F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts
  31. Cardiac 99mTc sestamibi SPECT and 18F FDG PET as viability markers in takotsubo cardiomyopathy
  32. Positron Emission Tomography Based Analysis of Long-Circulating Cross-Linked Triblock Polymeric Micelles in a U87MG Mouse Xenograft Model and Comparison of DOTA and CB-TE2A as Chelators of Copper-64
  33. BNP Predicts Chemotherapy-Related Cardiotoxicity and Death: Comparison with Gated Equilibrium Radionuclide Ventriculography
  34. Plasma plasminogen activator inhibitor-1 predicts myocardial infarction in HIV-1-infected individuals
  35. Endoscopic versus open radial artery harvest and mammario-radial versus aorto-radial grafting in patients undergoing coronary artery bypass surgery: protocol for the 2 × 2 factorial designed randomised NEO trial
  36. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature
  37. Injectable Colloidal Gold in a Sucrose Acetate Isobutyrate Gelating Matrix with Potential Use in Radiation Therapy
  38. PET/CT in therapy evaluation of patients with lung cancer
  39. Non-Invasive Imaging for Subclinical Coronary Atherosclerosis in Patients with Peripheral Artery Disease
  40. 18F-FDG and 18F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice
  41. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging
  42. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and 64Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors
  43. Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study
  44. Topotecan Monotherapy in Heavily Pretreated Patients with Progressive Advanced Stage Neuroendocrine Carcinomas
  45. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone
  46. Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET
  47. Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study
  48. Positron emission tomography of the vulnerable atherosclerotic plaque in man – a contemporary review
  49. Positron emission tomography/computed tomography for optimized colon cancer staging and follow up
  50. Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol
  51. Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study
  52. Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation
  53. The clinical value of cardiac sympathetic imaging in heart failure
  54. Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor
  55. Review: comparison of PET rubidium‐82 with conventional SPECT myocardial perfusion imaging
  56. Silent Ischemic Heart Disease and Pericardial Fat Volume in HIV-Infected Patients: A Case-Control Myocardial Perfusion Scintigraphy Study
  57. First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts
  58. Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study
  59. Urokinase‐type plasminogen activator receptor ( uPAR ) as a promising new imaging target: potential clinical applications
  60. High tumor uptake of 64Cu: Implications for molecular imaging of tumor characteristics with copper-based PET tracers
  61. [18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
  62. Imaging of Metastatic Lymph Nodes by X-ray Phase-Contrast Micro-Tomography
  63. [18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts
  64. Small animal positron emission tomography imaging andin vivostudies of atherosclerosis
  65. Plasma natriuretic peptides during supraventricular tachycardia: A study in patients with atrioventricular nodal reentry tachycardia
  66. Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome
  67. Improved PET Imaging of uPAR Expression Using new 64 Cu-labeled Cross-Bridged Peptide Ligands: Comparative in vitro and in vivo Studies
  68. PET/MRI in cancer patients: first experiences and vision from Copenhagen
  69. 18F-FDG PET Imaging of Murine Atherosclerosis: Association with Gene Expression of Key Molecular Markers
  70. [18F]FLT PET for Non-Invasive Assessment of Tumor Sensitivity to Chemotherapy: Studies with Experimental Chemotherapy TP202377 in Human Cancer Xenografts in Mice
  71. Importance of Attenuation Correction (AC) for Small Animal PET Imaging
  72. New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts
  73. Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI
  74. Takotsubo-cardiomyopathy: A case of extremely fast recovery described by multimodality cardiac imaging
  75. Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature
  76. PET imaging of liposomes labeled with an [18F]-fluorocholesteryl ether probe prepared by automated radiosynthesis
  77. Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study
  78. 64Cu-ATSM and 18FDG PET uptake and 64Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry
  79. The Combination of In vivo 124I-PET and CT Small Animal Imaging for Evaluation of Thyroid Physiology and Dosimetry
  80. Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model
  81. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers
  82. Cardiovascular disease in patients with HIV
  83. Changes in lung function of HIV-infected patients: a 4·5-year follow-up study
  84. Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT
  85. Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas
  86. 64Cu-NODAGA-c(RGDyK) Is a Promising New Angiogenesis PET Tracer: Correlation between Tumor Uptake and Integrin Expression in Human Neuroendocrine Tumor Xenografts
  87. 111Indium Labelling of Recombinant Activated Coagulation Factor VII: In Vitro and Preliminary In Vivo Studies in Healthy Rats
  88. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients
  89. Flow-Mediated Vasodilatation and Intima-Media Thickness in Patients with Coexisting Heart Failure and Diabetes Receiving Medical Therapy
  90. A randomized study of the effects of exercise training on patients with atrial fibrillation
  91. Welcome to Diagnostics: a New Open Access Journal for the Fast-Growing Field of Medical Diagnostics
  92. FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
  93. Preserved myocardial blood flow in the apical region involved in takotsubo cardiomyopathy by quantitative cardiac PET assessment
  94. Limited value of novel pulmonary embolism biomarkers in patients with coronary atherosclerosis
  95. Molecular Imaging with Small Animal PET/CT
  96. Microvessel Density But Not Neoangiogenesis Is Associated with 18F-FDG Uptake in Human Atherosclerotic Carotid Plaques
  97. Decreased Heart Rate Variability in HIV Positive Patients Receiving Antiretroviral Therapy: Importance of Blood Glucose and Cholesterol
  98. First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience
  99. Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer
  100. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina
  101. MESENCHYMAL STEM CELLS THERAPY IN PATIENTS WITH CHRONIC CORONARY ARTERY DISEASE: 12 MONTHS FOLLOW-UP
  102. 64Cu loaded liposomes as positron emission tomography imaging agents
  103. Use of Cis-[18F]Fluoro-Proline for Assessment of Exercise-Related Collagen Synthesis in Musculoskeletal Connective Tissue
  104. Carotid plaque imaging with FDG-PET and ultrasound
  105. Lung scintigraphy and pulmonary embolism
  106. Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Advanced Neuroendocrine Tumors: Results from a Danish Cohort Treated in Switzerland
  107. Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
  108. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
  109. Recombinant coagulation factor VIIa labelled with the fac-99 mTc(CO)3-core: synthesis and in vitro evaluation of a putative new radiopharmaceutical for imaging in acute bleeding lesion
  110. Fluorine-18 labelling of a series of potential EGFRvIII targeting peptides with a parallel labelling approach using [18F]FPyME
  111. Early Detection of Response to Experimental Chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in Human Ovary Cancer Xenografts in Mice
  112. When to image carotid plaque inflammation with FDG PET/CT
  113. Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study
  114. ANP, BNP and D-dimer predict right ventricular dysfunction in patients with acute pulmonary embolism
  115. Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides
  116. Reduction in coronary and peripheral vasomotor function in patients with HIV after initiation of antiretroviral therapy: a longitudinal study with positron emission tomography and flow-mediated dilation
  117. Gene Expression of ANP, BNP and ET-1 in the Heart of Rats during Pulmonary Embolism
  118. Estimating GFR in children with 99m Tc-DTPA renography: a comparison with single-sample 51 Cr-EDTA clearance
  119. Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
  120. Increased Cellular Proliferation in Rat Skeletal Muscle and Tendon in Response to Exercise: Use of FLT and PET/CT
  121. 18FDG PET and Ultrasound Echolucency in Carotid Artery Plaques
  122. Gene expression and 18FDG uptake in atherosclerotic carotid plaques
  123. FDG-PET predicts survival in neuroendocrine tumors
  124. Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients
  125. Comparison of V/Q SPECT and planar V/Q lung scintigraphy in diagnosing acute pulmonary embolism
  126. Regional Gene Expression of LOX-1, VCAM-1, and ICAM-1 in Aorta of HIV-1 Transgenic Rats
  127. Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells
  128. Noninvasive 64Cu-ATSM and PET/CT Assessment of Hypoxia in Rat Skeletal Muscles and Tendons During Muscle Contractions
  129. Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patients
  130. Identification of novel peptide ligands for the cancer-specific receptor mutation EFGRvIII using a mixture-based synthetic combinatorial library
  131. 18F-Fluorodeoxyglucose and PET/CT for noninvasive study of exercise-induced glucose uptake in rat skeletal muscle and tendon
  132. Radiation exposure to surgical staff during hyperthermic isolated limb perfusion with99mTechnetium labeled red blood cells
  133. Comparison of [18F]FBA and [18F]FPyMe as peptide radio-labeling agents of PEPHC1 for PET imaging of EGFRvIII
  134. Right and left sided cardiac function in HIV patients on anti-retroviral therapy: a cine magnetic resonance imaging study
  135. Gene expression of LOX-1, VCAM-1, and ICAM-1 in pre-atherosclerotic mice
  136. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper
  137. Identification of Amino Acid Residues in PEPHC1 Important for Binding to the Tumor-Specific Receptor EGFRvIII
  138. Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia
  139. ANP and BNP in atrial fibrillation before and after cardioversion – and their relationship to cardiac volume and function
  140. BNP cannot replace gated equilibrium radionuclide ventriculography in monitoring of anthracycline-induced cardiotoxity
  141. Quantitative Gene Expression of Somatostatin Receptors and Noradrenaline Transporter Underlying Scintigraphic Results in Patients with Neuroendocrine Tumors
  142. Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability
  143. Prognostic Usefulness of Anemia and N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Systolic Heart Failure
  144. Independent effects of both right and left ventricular function on plasma brain natriuretic peptide
  145. Anaemia and NT-proBNP Are Associated and Carry Independent Prognostic Information in Chronic Heart Failure Patients
  146. The relationship between N-terminal pro–brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure
  147. Added value of combined simultaneous lung ventilation?perfusion single-photon emission computed tomography/multi-slice-computed tomography angiography in two patients suspected of having acute pulmonary embolism
  148. Carotid intima?media thickness in HIV patients treated with antiretroviral therapy
  149. Advanced Quantitative Echocardiography in Arrhythmogenic Right Ventricular Cardiomyopathy
  150. Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state
  151. Long-Term Clinical Variation of N-Terminal-Pro-Brain-Natriuretic-Peptide in Stable Chronic Heart Failure Patients
  152. Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake
  153. Increased Susceptibility to Diet-Induced Obesity in Histamine-Deficient Mice
  154. Molecular Imaging of Cancer Using PET and SPECT
  155. Positron Emission Tomographic Evaluation of Regulation of Myocardial Perfusion in Physiological (Elite Athletes) and Pathological (Systemic Hypertension) Left Ventricular Hypertrophy
  156. Right-sided cardiac function in healthy volunteers measured by first-pass radionuclide ventriculography and gated blood-pool SPECT: comparison with cine MRI
  157. Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure
  158. Impact of medical treatment on lung diffusion capacity in elderly patients with heart failure
  159. 16S rDNA sequencing revealed Citrobacter freundii as the cause of liver abcess after banding of rectal haemorrhoids
  160. Bone infection in patients suspected of complicating osteomyelitis: the diagnostic value of dual isotope bone-granulocyte scintigraphy
  161. Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction
  162. Reply
  163. Fever of unknown origin: prospective comparison of diagnostic value of 18 F-FDG PET and 111 In-granulocyte scintigraphy
  164. Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography
  165. Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects
  166. Combined Indium-111 Octreotide Scintigraphy and Low-Dose Computed Tomography in Localization of Neuroendocrine Tumors
  167. Primary Diagnosis of Multiple Pheochromocytomas in the Brother of a MEN-2 Patient by Simultaneous MIBG Scintigraphy and Low-Dose Computed Tomography
  168. Neurohumoral prediction of left-ventricular morphologic response to β-blockade with metoprolol in chronic left-ventricular systolic heart failure
  169. Utility of Planar Bone Scintigraphy To Distinguish Benign Osteochondromas from Malignant Chondrosarcomas
  170. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations
  171. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives
  172. Editorial
  173. Myocardial Hibernation – Land of Ignorance
  174. Histaminergic and Catecholaminergic Interactions in the Central Regulation of Vasopressin and Oxytocin Secretion1
  175. Serotonergic involvement in stress-induced ACTH release
  176. Copper release from copper intrauterine devices removed after up to 8 years of use
  177. Central Activin Administration Modulates Corticotropin Releasing Hormone and Adrenocorticotropin Secretion*
  178. Mediation of the Stress-Induced Prolactin Release by Hypothalamic Histaminergic Neurons and the Possible Involvement of Vasopressin in This Response*
  179. Metabolic changes during treatment with two different progestogens